{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:29:08Z","timestamp":1787020148796,"version":"build-2736575974"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T00:00:00Z","timestamp":1757980800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T00:00:00Z","timestamp":1757980800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002352","name":"Ain Shams University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002352","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Macrolide-resistant and methicillin-resistant\n                      <jats:italic>Staphylococcus aureus<\/jats:italic>\n                      , particularly those exhibiting pristinamycin resistance, impose significant medical health consequences with limited therapeutic options. This study is designed to determine their prevalence in a major tertiary care hospital in Egypt, antimicrobial susceptibility and evaluate various pristinamycin (PST)-antibiotic combinations.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Standard procedures were employed for isolation, identification, antimicrobial susceptibility, and molecular analysis of key macrolide- and methicillin-resistant genes. Phenotypic relatedness and antibiotic combinations of pristinamycin with other antimicrobial agents were done using the heatmap analysis and checkerboard assay.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Out of 154 positive cultures of\n                      <jats:italic>S. aureus<\/jats:italic>\n                      were collected from different types of skin infections. The lowest resistance was shown for linezolid (5.2%), followed by vancomycin (9.1%), teicoplanin (9.1%), chloramphenicol (12.3%), and doxycycline (14.9%). The MDR isolates (43%,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200967) showed diverse phenotypic relatedness. They showed multiple antibiotic resistance (MAR) index range from 0.31\u20131.0, exhibiting 100% non-susceptibility to cefoxitin (MRSA), erythromycin, and clarithromycin known as macrolide resistant\n                      <jats:italic>S. aureus<\/jats:italic>\n                      (McRSA), followed by 80%, 74.6%, and 46.2% for clindamycin, azithromycin, and PST, respectively. All the MDR isolates gave positive\n                      <jats:italic>nuc<\/jats:italic>\n                      ,\n                      <jats:italic>mec<\/jats:italic>\n                      A and confirmed MRSA. The\n                      <jats:italic>erm<\/jats:italic>\n                      C,\n                      <jats:italic>erm<\/jats:italic>\n                      A, and\n                      <jats:italic>msr<\/jats:italic>\n                      A, genes were detected in 49.25%, 26.8%, and 23.8% of the MDR isolates, respectively. The PST-doxycycline and PST-levofloxacin combinations were mostly synergistic in 82.13% and 70.14%, while PST-linezolid showed mostly additive effects in 67% of the MDR\n                      <jats:italic>S. aureus<\/jats:italic>\n                      isolates.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      This study highlights the high prevalence of MRSA isolates recovered from various skin infections. Linezolid, vancomycin, teicoplanin, pristinamycin, chloramphenicol, and doxycycline remain effective therapeutic options. Macrolide and methicillin resistance are increasingly developing among\n                      <jats:italic>S. aureus<\/jats:italic>\n                      clinical isolates. The pristinamycin combination with doxycycline or levofloxacin was mostly synergistic and recommended for clinical evaluation.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-025-11433-0","type":"journal-article","created":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T06:04:39Z","timestamp":1758002679000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Pristinamycin-antibiotic combinations against methicillin-resistant Staphylococcus aureus recovered from skin infections"],"prefix":"10.1186","volume":"25","author":[{"given":"Muath","family":"Suliman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amr S.","family":"Bishr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally T. K.","family":"Tohamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samar S.","family":"Mabrouk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasser S. M.","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdallah M.","family":"Samy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled M.","family":"Aboshanab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,16]]},"reference":[{"key":"11433_CR1","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.idc.2020.10.003","volume":"35","author":"TJ Hatlen","year":"2021","unstructured":"Hatlen TJ, Miller LG. Staphylococcal skin and soft tissue infections. Infect Dis Clin North Am. 2021;35:81\u2013105. https:\/\/doi.org\/10.1016\/j.idc.2020.10.003.","journal-title":"Infect Dis Clin North Am"},{"key":"11433_CR2","doi-asserted-by":"publisher","first-page":"4589","DOI":"10.2147\/IDR.S284781","volume":"13","author":"Q Dong","year":"2020","unstructured":"Dong Q, Liu Y, Li W, Chen M, Li W, Wang X, et al. Phenotypic and molecular characteristics of community-associated staphylococcus aureus infection in neonates. Infect Drug Resist. 2020;13:4589\u2013600. https:\/\/doi.org\/10.2147\/IDR.S284781.","journal-title":"Infect Drug Resist"},{"key":"11433_CR3","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00181-19","author":"DMP De Oliveira","year":"2020","unstructured":"De Oliveira DMP, Forde BM, Kidd TJ, Harris PNA, Schembri MA, Beatson SA, et al. Antimicrobial resistance in ESKAPE pathogens. Clin Microbiol Rev. 2020. https:\/\/doi.org\/10.1128\/CMR.00181-19.","journal-title":"Clin Microbiol Rev"},{"key":"11433_CR4","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1097\/SLA.0000000000002504","volume":"269","author":"KG Barki","year":"2019","unstructured":"Barki KG, Das A, Dixith S, Ghatak PD, Mathew-Steiner S, Schwab E, et al. Electric field based dressing disrupts mixed-species bacterial biofilm infection and restores functional wound healing. Ann Surg. 2019;269:756\u201366. https:\/\/doi.org\/10.1097\/SLA.0000000000002504.","journal-title":"Ann Surg"},{"issue":"10","key":"11433_CR5","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.3390\/antibiotics10111377","volume":"10","author":"O Simonetti","year":"2021","unstructured":"Simonetti O, Rizzetto G, Radi G, Molinelli E, Cirioni O, Giacometti A, et al. New perspectives on old and new therapies of staphylococcal skin infections: the role of biofilm targeting in wound healing. Antibiotics. 2021;10(10):1377. https:\/\/doi.org\/10.3390\/antibiotics10111377.","journal-title":"Antibiotics"},{"key":"11433_CR6","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1099\/mgen.0.000324","volume":"1","author":"SG Giulieri","year":"2020","unstructured":"Giulieri SG, Tong SYC, Williamson DA. Using genomics to understand meticillin- and vancomycin-resistant Staphylococcus aureus infections. Microb Genom. 2020;1:6. https:\/\/doi.org\/10.1099\/mgen.0.000324.","journal-title":"Microb Genom"},{"key":"11433_CR7","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3389\/fmolb.2022.1035574","volume":"14","author":"AH Nguyen","year":"2022","unstructured":"Nguyen AH, Hood KS, Mileykovskaya E, Miller WR, Tran TT. Bacterial cell membranes and their role in daptomycin resistance: A review. Front Mol Biosci. 2022;14:9. https:\/\/doi.org\/10.3389\/fmolb.2022.1035574.","journal-title":"Front Mol Biosci"},{"issue":"1","key":"11433_CR8","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1093\/cid\/ciy399","volume":"68","author":"EY Klein","year":"2019","unstructured":"Klein EY, Jiang W, Mojica N, Tseng KK, McNeill R, Cosgrove SE, et al. National costs associated with methicillin-susceptible and methicillin-resistant Staphylococcus aureus hospitalizations in the United States, 2010\u20132014. Clin Infect Dis. 2019;68(1):22\u20138. https:\/\/doi.org\/10.1093\/cid\/ciy399.","journal-title":"Clin Infect Dis"},{"key":"11433_CR9","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jhin.2022.07.004","volume":"129","author":"S Miyakis","year":"2022","unstructured":"Miyakis S, Brentnall S, Masso M, Reynolds G, Byrne MK, Newton P, et al. Key predictors and burden of meticillin-resistant Staphylococcus aureus infection in comparison with meticillin-susceptible S. aureus infection in an Australian hospital setting. J Hosp Infect. 2022;129:41\u20138. https:\/\/doi.org\/10.1016\/j.jhin.2022.07.004.","journal-title":"J Hosp Infect"},{"key":"11433_CR10","doi-asserted-by":"publisher","DOI":"10.1128\/cmr.00148-22","author":"J-H Jiang","year":"2023","unstructured":"Jiang J-H, Cameron DR, Nethercott C, Aires-de-Sousa M, Peleg AY. Virulence attributes of successful methicillin-resistant Staphylococcus aureus lineages. Clin Microbiol Rev. 2023. https:\/\/doi.org\/10.1128\/cmr.00148-22.","journal-title":"Clin Microbiol Rev"},{"issue":"8","key":"11433_CR11","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s13756-019-0576-5","volume":"23","author":"F Zhao","year":"2019","unstructured":"Zhao F, Li J, Liu J, Guan X, Gong J, Liu L, et al. Antimicrobial susceptibility and molecular characteristics of Mycoplasma pneumoniae isolates across different regions of China. Antimicrob Resist Infect Control. 2019;23(8):143. https:\/\/doi.org\/10.1186\/s13756-019-0576-5.","journal-title":"Antimicrob Resist Infect Control"},{"key":"11433_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41421-024-00702-y","author":"C-X Ma","year":"2024","unstructured":"Ma C-X, Li Y, Liu W-T, Li Y, Zhao F, Lian X-T, et al. Synthetic macrolides overcoming MLSBK-resistant pathogens. Cell Discov. 2024. https:\/\/doi.org\/10.1038\/s41421-024-00702-y.","journal-title":"Cell Discov"},{"key":"11433_CR13","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1055\/a-1293-9655","volume":"32","author":"Q Li","year":"2021","unstructured":"Li Q, Seiple IB. Modular synthesis of streptogramin antibiotics. Synlett. 2021;32:647\u201354. https:\/\/doi.org\/10.1055\/a-1293-9655.","journal-title":"Synlett"},{"key":"11433_CR14","doi-asserted-by":"publisher","unstructured":"Bishr AS, Abdelaziz SM, Yahia IS, Yassien MA, Hassouna NA, Aboshanab KM. Association of macrolide resistance genotypes and synergistic antibiotic combinations for combating macrolide-resistant mrsa recovered from hospitalized patients. Biology (Basel). 2021;10. https:\/\/doi.org\/10.3390\/biology10070624.","DOI":"10.3390\/biology10070624"},{"key":"11433_CR15","doi-asserted-by":"publisher","unstructured":"Aronson JK. Streptogramins. In: Meyler\u2019s Side Effects of Drugs. Elsevier; 2016. p. 499.https:\/\/doi.org\/10.1016\/B978-0-444-53717-1.01472-4.","DOI":"10.1016\/B978-0-444-53717-1.01472-4"},{"key":"11433_CR16","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.jhin.2024.09.009","volume":"153","author":"SM Shin","year":"2024","unstructured":"Shin SM, Lee Y, Heo E, Kim H-S, Jeong YM, Lee J, et al. Prescription of oral antibiotics and its appropriateness for outpatients in a tertiary care hospital in Korea. J Hosp Infect. 2024;153:81\u20139. https:\/\/doi.org\/10.1016\/j.jhin.2024.09.009.","journal-title":"J Hosp Infect"},{"key":"11433_CR17","doi-asserted-by":"publisher","unstructured":"Scholar E. Pristinamycin. In: xPharm: The Comprehensive Pharmacology Reference. Elsevier; 2007. p. 1\u20133.https:\/\/doi.org\/10.1016\/B978-008055232-3.62460-2.","DOI":"10.1016\/B978-008055232-3.62460-2"},{"key":"11433_CR18","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.ijmm.2013.08.008","volume":"304","author":"Y Mast","year":"2014","unstructured":"Mast Y, Wohlleben W. Streptogramins \u2013 two are better than one! Int J Med Microbiol. 2014;304:44\u201350. https:\/\/doi.org\/10.1016\/j.ijmm.2013.08.008.","journal-title":"Int J Med Microbiol"},{"key":"11433_CR19","doi-asserted-by":"publisher","first-page":"328","DOI":"10.3201\/eid2402.170902","volume":"24","author":"TRH Read","year":"2018","unstructured":"Read TRH, Jensen JS, Fairley CK, Grant M, Danielewski JA, Su J, et al. Use of pristinamycin for macrolide-resistant Mycoplasma genitalium infection. Emerg Infect Dis. 2018;24:328\u201335. https:\/\/doi.org\/10.3201\/eid2402.170902.","journal-title":"Emerg Infect Dis"},{"key":"11433_CR20","doi-asserted-by":"publisher","first-page":"e71","DOI":"10.1016\/j.patbio.2011.10.012","volume":"60","author":"S Mezghani Maalej","year":"2012","unstructured":"Mezghani Maalej S, Malbruny B, Leclercq R, Hammami A. Emergence of Staphylococcus aureus strains resistant to pristinamycin in Sfax (Tunisia). Pathol Biol (Paris). 2012;60:e71\u20134. https:\/\/doi.org\/10.1016\/j.patbio.2011.10.012.","journal-title":"Pathol Biol (Paris)"},{"key":"11433_CR21","doi-asserted-by":"publisher","first-page":"47","DOI":"10.4103\/0253-7613.48884","volume":"41","author":"S Keshari","year":"2009","unstructured":"Keshari S, Kapoor A, Kastury N, Singh D, Bhargava A. Emergence of pristinamycin resistance in India. Indian J Pharmacol. 2009;41:47. https:\/\/doi.org\/10.4103\/0253-7613.48884.","journal-title":"Indian J Pharmacol"},{"key":"11433_CR22","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1111\/j.1469-0691.2005.01199.x","volume":"11","author":"P B\u00e9mer","year":"2005","unstructured":"B\u00e9mer P, Juvin M-E, Corvec S, Ros A, Drugeon H. Correlation of agar dilution and VITEK2 system for detection of resistance to macrolides, lincosamides and pristinamycin among Staphylococcus aureus and Staphylococcus epidermidis: association with genotypes. Clin Microbiol Infect. 2005;11:656\u201361. https:\/\/doi.org\/10.1111\/j.1469-0691.2005.01199.x.","journal-title":"Clin Microbiol Infect"},{"key":"11433_CR23","volume-title":"Bergey\u2019s manual of determinative bacteriology","author":"JGKNSP Holt","year":"1994","unstructured":"Holt JGKNSP. Bergey\u2019s manual of determinative bacteriology. 9th ed. Baltimore, USA: Lippincott Williams and Wilkins; 1994.","edition":"9"},{"key":"11433_CR24","unstructured":"CLSI. CLSI: Performance standards for antimicrobial susceptibility testing, vol. M100-Ed31. 35th ed. Clin Lab Standards Institute; 2021. https:\/\/cdn.bfldr.com\/YLD4EVFU\/at\/hvshwc8rxbsbnnmtqp9f3886\/m100ed35e_sample.pdf. Accessed 20 May 2025."},{"key":"11433_CR25","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","volume":"18","author":"A-P Magiorakos","year":"2012","unstructured":"Magiorakos A-P, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18:268\u201381. https:\/\/doi.org\/10.1111\/j.1469-0691.2011.03570.x.","journal-title":"Clin Microbiol Infect"},{"key":"11433_CR26","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1128\/aem.46.1.165-170.1983","volume":"46","author":"PH Krumperman","year":"1983","unstructured":"Krumperman PH. Multiple antibiotic resistance indexing of Escherichia coli to identify high-risk sources of fecal contamination of foods. Appl Environ Microbiol. 1983;46:165\u201370. https:\/\/doi.org\/10.1128\/aem.46.1.165-170.1983.","journal-title":"Appl Environ Microbiol"},{"key":"11433_CR27","doi-asserted-by":"publisher","first-page":"103613","DOI":"10.1016\/j.sjbs.2023.103613","volume":"30","author":"F Asghar","year":"2023","unstructured":"Asghar F, Bano A, Waheed F, Ahmed Anjum A, Ejaz H, Javed N. Association of exogenous factors with molecular epidemiology of Staphylococcus aureus in human oral cavity. Saudi J Biol Sci. 2023;30:103613. https:\/\/doi.org\/10.1016\/j.sjbs.2023.103613.","journal-title":"Saudi J Biol Sci"},{"key":"11433_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s12866-022-02660-5","author":"NA Kamel","year":"2022","unstructured":"Kamel NA, Tohamy ST, Yahia IS, Aboshanab KM. Insights on the performance of phenotypic tests versus genotypic tests for the detection of carbapenemase-producing gram-negative bacilli in resource-limited settings. BMC Microbiol. 2022. https:\/\/doi.org\/10.1186\/s12866-022-02660-5.","journal-title":"BMC Microbiol"},{"key":"11433_CR29","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/0732-8893(93)90087-N","volume":"16","author":"MH Hsieh","year":"1993","unstructured":"Hsieh MH, Yu CM, Yu VL, Chow JW. Synergy assessed by checkerboard a critical analysis. Diagn Microbiol Infect Dis. 1993;16:343\u20139. https:\/\/doi.org\/10.1016\/0732-8893(93)90087-N.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"11433_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s12866-023-02934-6","author":"SS Mabrouk","year":"2023","unstructured":"Mabrouk SS, Abdellatif GR, Zaid ASA, Aboshanab KM. Propranolol restores susceptibility of XDR gram-negative pathogens to meropenem and meropenem combination has been evaluated with either tigecycline or amikacin. BMC Microbiol. 2023. https:\/\/doi.org\/10.1186\/s12866-023-02934-6.","journal-title":"BMC Microbiol"},{"key":"11433_CR31","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s12879-019-3779-8","volume":"19","author":"W Yao","year":"2019","unstructured":"Yao W, Xu G, Li D, Bai B, Wang H, Cheng H, et al. Staphylococcus aureus with an erm-mediated constitutive macrolide-lincosamide-streptogramin B resistance phenotype has reduced susceptibility to the new ketolide, solithromycin. BMC Infect Dis. 2019;19:175. https:\/\/doi.org\/10.1186\/s12879-019-3779-8.","journal-title":"BMC Infect Dis"},{"key":"11433_CR32","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jhin.2024.11.017","volume":"156","author":"E Pouly","year":"2025","unstructured":"Pouly E, Biguenet A, Cholley P, Hocquet D, Bertrand X. Outbreak of multidrug-resistant Staphylococcus haemolyticus ST29 in a French neonatal unit. J Hosp Infect. 2025;156:17\u201320. https:\/\/doi.org\/10.1016\/j.jhin.2024.11.017.","journal-title":"J Hosp Infect"},{"key":"11433_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jhin.2021.12.005","volume":"122","author":"MJ Stone","year":"2022","unstructured":"Stone MJ, Swales C, Bond SE, Muthayya P, Sarma JB. An outbreak of livestock-associated meticillin-resistant Staphylococcus aureus (LA-MRSA) clonal complex 398 in a regional burns centre. J Hosp Infect. 2022;122:1\u20138. https:\/\/doi.org\/10.1016\/j.jhin.2021.12.005.","journal-title":"J Hosp Infect"},{"key":"11433_CR34","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3389\/fmicb.2023.1220286","volume":"26","author":"A El Mammery","year":"2023","unstructured":"El Mammery A, de Ram\u00edrez Arellano E, Ca\u00f1ada-Garc\u00eda JE, Cercenado E, Villar-G\u00f3mara L, Casquero-Garc\u00eda V, et al. An increase in erythromycin resistance in methicillin-susceptible Staphylococcus aureus from blood correlates with the use of macrolide\/lincosamide\/streptogramin antibiotics. EARS-Net Spain (2004\u20132020). Front Microbiol. 2023;26:14. https:\/\/doi.org\/10.3389\/fmicb.2023.1220286.","journal-title":"Front Microbiol."},{"key":"11433_CR35","doi-asserted-by":"publisher","first-page":"415","DOI":"10.30699\/ijp.2023.1987077.3049","volume":"18","author":"M Manouchehrifar","year":"2023","unstructured":"Manouchehrifar M, Khademi F, Peeri Doghaheh H, Habibzadeh S, Arzanlou M. Macrolide-lincosamide resistance and virulence genes in staphylococcus aureus isolated from clinical specimens in ardabil. Iran Iran J Pathol. 2023;18:415\u201324. https:\/\/doi.org\/10.30699\/ijp.2023.1987077.3049.","journal-title":"Iran. Iran J Pathol."},{"issue":"10","key":"11433_CR36","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.3390\/antibiotics10111406","volume":"17","author":"M Miklasi\u0144ska-Majdanik","year":"2021","unstructured":"Miklasi\u0144ska-Majdanik M. Mechanisms of Resistance to Macrolide Antibiotics among Staphylococcus aureus. Antibiotics. 2021;17(10):1406. https:\/\/doi.org\/10.3390\/antibiotics10111406.","journal-title":"Antibiotics"},{"key":"11433_CR37","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.plasmid.2018.05.001","volume":"99","author":"AT Fe\u00dfler","year":"2018","unstructured":"Fe\u00dfler AT, Wang Y, Wu C, Schwarz S. Mobile macrolide resistance genes in staphylococci. Plasmid. 2018;99:2\u201310. https:\/\/doi.org\/10.1016\/j.plasmid.2018.05.001.","journal-title":"Plasmid"},{"key":"11433_CR38","doi-asserted-by":"publisher","first-page":"110968","DOI":"10.1016\/j.ijfoodmicro.2024.110968","volume":"427","author":"HA Elshebrawy","year":"2025","unstructured":"Elshebrawy HA, Kasem NG, Sallam KI. Methicillin- and vancomycin-resistant Staphylococcus aureus in chicken carcasses, ready-to-eat chicken meat sandwiches, and buffalo milk. Int J Food Microbiol. 2025;427:110968. https:\/\/doi.org\/10.1016\/j.ijfoodmicro.2024.110968.","journal-title":"Int J Food Microbiol"},{"issue":"14","key":"11433_CR39","doi-asserted-by":"publisher","first-page":"30606","DOI":"10.1038\/s41598-024-81516-6","volume":"23","author":"YH Tartor","year":"2024","unstructured":"Tartor YH, Enany ME, Ismail NI, El-Demerdash AS, Eidaroos NH, Algendy RM, et al. Vancomycin-resistant Staphylococcus aureus endangers Egyptian dairy herds. Sci Rep. 2024;23(14):30606. https:\/\/doi.org\/10.1038\/s41598-024-81516-6.","journal-title":"Sci Rep"},{"key":"11433_CR40","doi-asserted-by":"publisher","first-page":"4496","DOI":"10.1038\/s41598-025-88743-5","volume":"6","author":"R Mohammed","year":"2025","unstructured":"Mohammed R, Nader SM, Hamza DA, Sabry MA. Public health implications of multidrug-resistant and methicillin-resistant Staphylococcus aureus in retail oysters. Sci Rep. 2025;6:4496. https:\/\/doi.org\/10.1038\/s41598-025-88743-5.","journal-title":"Sci Rep"},{"issue":"19","key":"11433_CR41","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1080\/14787210.2021.1834851","volume":"4","author":"S Reissier","year":"2021","unstructured":"Reissier S, Cattoir V. Streptogramins for the treatment of infections caused by Gram-positive pathogens. Expert Rev Anti Infect Ther. 2021;4(19):587\u201399. https:\/\/doi.org\/10.1080\/14787210.2021.1834851.","journal-title":"Expert Rev Anti Infect Ther"},{"key":"11433_CR42","doi-asserted-by":"publisher","first-page":"3949","DOI":"10.1128\/AAC.00212-10","volume":"54","author":"AB Reid","year":"2010","unstructured":"Reid AB, Daffy JR, Stanley P, Buising KL. Use of pristinamycin for infections by Gram-positive bacteria: clinical experience at an Australian hospital. Antimicrob Agents Chemother. 2010;54:3949\u201352. https:\/\/doi.org\/10.1128\/AAC.00212-10.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"11433_CR43","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1093\/jac\/dki108","volume":"55","author":"J Ng","year":"2005","unstructured":"Ng J, Gosbell IB. Successful oral pristinamycin therapy for osteoarticular infections due to methicillin-resistant Staphylococcus aureus (MRSA) and other Staphylococcus spp. J Antimicrob Chemother. 2005;55(1):1008\u201312. https:\/\/doi.org\/10.1093\/jac\/dki108.","journal-title":"J Antimicrob Chemother"},{"key":"11433_CR44","doi-asserted-by":"publisher","first-page":"3317","DOI":"10.1093\/jac\/dkw256","volume":"71","author":"AJ Plant","year":"2016","unstructured":"Plant AJ, Auckland C. Pristinamycin in the treatment of MSSA bone and joint infection. J Antimicrob Chemother. 2016;71:3317\u20133317. https:\/\/doi.org\/10.1093\/jac\/dkw256.","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"11433_CR45","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1093\/jac\/dkg143","volume":"51","author":"SJ Dancer","year":"2003","unstructured":"Dancer SJ. Oral streptogramins in the management of patients with methicillin-resistant Staphylococcus aureus (MRSA) infections. J Antimicrob Chemother. 2003;51(1):731\u20135. https:\/\/doi.org\/10.1093\/jac\/dkg143.","journal-title":"J Antimicrob Chemother"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11433-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11433-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11433-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T06:04:41Z","timestamp":1758002681000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11433-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,16]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11433"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11433-0","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,16]]},"assertion":[{"value":"20 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Faculty of Pharmacy, Ain Shams University Research Ethics Committee (ACUC-FP-ASU RHDIRB2020110301 -Nr. 94b), with the waiving of the patient consent since there was no patient contact and the isolates were obtained from unidentified clinical specimens discharged from the general microbiology diagnostic laboratory of the hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1107"}}